Adocia Stock Börse Stuttgart
Stocks
A89
FR0011184241
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.169 EUR | +1.19% |
|
+0.73% | -35.32% |
| 06-08 | Adocia presents Phase 3 study data |  |
| 06-08 | Adocia Presents Full Phase 3 Results For BioChaperone Lispro In Type 2 Diabetes Presented at ADA 86th Scientific Sessions | CI |
| Market Cap | 81M 92.54M 74.77M 69.75M 131M 8.75B 134M 897M 348M 4.32B 348M 340M 15.04B | P/E 2026 * |
16.7x | P/E 2027 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 32.24M 36.83M 29.76M 27.76M 52.3M 3.48B 53.24M 357M 139M 1.72B 138M 135M 5.99B | EV / Sales 2026 * |
0.84x | EV / Sales 2027 * | -0.71x |
| Free-Float |
89.7% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | +0.73% | ||
| Current month | -15.85% | ||
| 1 month | -15.85% | ||
| 3 months | -10.63% | ||
| 6 months | -35.32% | ||
| Current year | -35.32% |
| 1 week | 3.88 |  | 4.27 |
| 1 month | 3.88 | | 4.95 |
| 3 years | 3 | | 14.84 |
| 5 years | 2.72 | | 14.84 |
| 10 years | 2.72 | | 62.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Soula
CEO | Chief Executive Officer | 55 | 2023-05-10 |
| Director of Finance/CFO | - | 2024-09-22 | |
Martin Gaudier
CTO | Chief Tech/Sci/R&D Officer | - | 2014-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Olivier Soula
BRD | Director/Board Member | 55 | 2013-04-18 |
Gérard Soula
CHM | Chairman | 80 | 2012-02-23 |
| Director/Board Member | 58 | 2013-06-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | +0.73% | +10.01% | +3.91% | 92.54M | |
| -0.47% | +7.63% | +69.44% | +130.60% | 57.65B | |
| -1.32% | +17.12% | +79.02% | +99.82% | 55.14B | |
| -1.28% | +2.68% | -12.60% | -13.79% | 23.53B | |
| +1.79% | +4.38% | +5.94% | +405.31% | 23.11B | |
| -1.93% | +11.11% | +34.89% | -7.86% | 18.14B | |
| -0.32% | +5.06% | +36.50% | -30.43% | 16.84B | |
| +0.24% | +5.98% | +23.45% | +184.72% | 13.68B | |
| +0.14% | +9.60% | +33.31% | - | 12.97B | |
| +1.83% | +4.58% | +77.42% | +132.45% | 12.38B | |
| Average | -0.17% | +5.68% | +35.74% | +100.53% | 25.94B | |
| Weighted average by Cap. | -0.49% | +4.87% | +47.79% | +116.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.39M 43.86M 35.44M 33.05M 62.28M 4.15B 63.39M 425M 165M 2.05B 165M 161M 7.13B | 14.75M 16.85M 13.62M 12.7M 23.93M 1.59B 24.36M 163M 63.41M 786M 63.32M 61.9M 2.74B |
| Net income | 3.98M 4.54M 3.67M 3.42M 6.45M 430M 6.57M 44.03M 17.09M 212M 17.07M 16.69M 738M | -8.01M -9.15M -7.39M -6.9M -12.99M -865M -13.23M -88.68M -34.43M -427M -34.37M -33.61M -1.49B |
| Net Debt | -48.77M -55.71M -45.02M -41.99M -79.12M -5.27B -80.53M -540M -210M -2.6B -209M -205M -9.06B | -91.47M -105M -84.44M -78.76M -148M -9.88B -151M -1.01B -393M -4.88B -393M -384M -16.99B |
| Date | Price | Change |
|---|---|---|
| 26-07-01 | €4.110 | -0.24% |
| 26-06-30 | €4.120 | +1.43% |
| 26-06-29 | €4.062 | -3.29% |
| 26-06-26 | €4.200 | +7.14% |
| 26-06-25 | €3.920 | -1.36% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADOC Stock
- A89 Stock
Select your edition
All financial news and data tailored to specific country editions
